You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

HCV Genotype 1

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hepatitis C Trial in Seoul

Completed
  • Hepatitis C
    • Seoul, Korea, Republic of
      Local Institution
    Jan 6, 2022

    Chronic Hepatitis C, Hepatitis C Virus, HCV Trial (ABT-493, ABT-530)

    Completed
    Has Results
    • Chronic Hepatitis C
    • +2 more
    • (no location specified)
    Jul 9, 2021

    Hepatitis C Trial in Bradford, London, Nottingham (Telaprevir, 40 Kd Pegylated interferon alfa 2a, Ribavirin)

    Completed
    • Hepatitis C
    • Bradford, United Kingdom
    • +3 more
    Jan 4, 2023

    Hepatitis C Trial in Denver (Simeprivir (SMV), Sofosbuvir (SOF), Ribavirin (RBV))

    Terminated
    Has Results
    • Hepatitis C
    • Simeprivir (SMV)
    • +2 more
    • Denver, Colorado
      University of Colorado Denver (Leprino Building)
    Aug 16, 2021

    Zepatier in Patients With Substance Use

    Active, not recruiting
    • Hepatitis C
    • +3 more
    • Elbasvir/Grazoprevir 50 MG-100 MG Oral Tablet [ZEPATIER]
    • Chicago, Illinois
      University of Illinois at Chicago
    Jun 28, 2022

    Chronic Hepatitis C Infection, Compensated Cirrhosis Trial (ABT-450/r/ABT-267, ABT-333, Ribavirin (RBV))

    Completed
    Has Results
    • Chronic Hepatitis C Infection
    • Compensated Cirrhosis
    • ABT-450/r/ABT-267, ABT-333
    • Ribavirin (RBV)
    • (no location specified)
    Jul 8, 2021

    Chronic Hepatics C Virus (HCV) Genotype 1, Non-Cirrhotic, Cirrhosis Trial in Beijing (TG-2349, DAG181, Ribavirin)

    Completed
    • Chronic Hepatics C Virus (HCV) Genotype 1
    • +3 more
    • Beijing, China
      Beijing Tsinghua Changgung Hospital
    Feb 2, 2021

    Hepatitis C Virus Infection, Human Immunodeficiency Virus Infection, Chronic Hepatitis C Trial (ABT-493 coformulated with

    Completed
    Has Results
    • Hepatitis C Virus Infection
    • +3 more
    • ABT-493 coformulated with ABT-530
    • (no location specified)
    Jul 9, 2021

    Hepatitis C, Chronic Trial in Taiwan (PEGASYS 180 µg Q1W, P1101 180 µg Q1W, 48 doses, P1101 270µg Q1W, 48 doses)

    Completed
    • Hepatitis C, Chronic
    • PEGASYS 180 µg Q1W
    • +3 more
    • Changhua, Taiwan
    • +12 more
    Oct 7, 2021

    Hepatitis C Trial in Rotterdam (Peginterferon alfa-2a, Interferon alfa-2a, Ribavirin)

    Completed
    • Hepatitis C
    • Peginterferon alfa-2a
    • +2 more
    • Rotterdam, Netherlands
      Erasmus Medical Center
    Aug 26, 2021

    Chronic Hepatitis C Infection, Compensated Cirrhosis Trial (Ombitasvir/Paritaprevir/Ritonavir, Dasabuvir)

    Completed
    Has Results
    • Chronic Hepatitis C Infection
    • Compensated Cirrhosis
    • (no location specified)
    Jul 8, 2021

    Chronic Hepatics C Virus (HCV) Genotype 1, Non-Cirrhotic, Cirrhosis Trial in Beijing (non-cirrhotic subjects. low TG-2349+ low

    Completed
    • Chronic Hepatics C Virus (HCV) Genotype 1
    • +3 more
    • non-cirrhotic subjects. low TG-2349+ low DAG181+Ribavirin
    • +5 more
    • Beijing, Beijing, China
      Peking University Peoples Hospital
    Feb 16, 2021

    Chronic Hepatitis C, Hepatitis C Virus, Compensated Cirrhosis Trial (ABT-493, ABT-530, ABT-450/r/ABT-267, ABT-333)

    Completed
    Has Results
    • Chronic Hepatitis C
    • +2 more
    • (no location specified)
    Jul 8, 2021

    HIV Infection, Hepatitis C Infection Trial in Puerto Rico, United States (Nitazoxanide (NTZ), Pegylated interferon alfa-2a

    Completed
    Has Results
    • HIV Infection
    • Hepatitis C Infection
    • Nitazoxanide (NTZ)
    • +2 more
    • Birmingham, Alabama
    • +17 more
    Nov 2, 2021

    Chronic Hepatitis C, Hepatitis C Virus, HCV Trial (ABT-493/ABT-530)

    Completed
    Has Results
    • Chronic Hepatitis C
    • +2 more
    • (no location specified)
    Jul 9, 2021

    Hepatitis C Infection, Hepatitis C Virus Trial (ombitasvir/paritaprevir/ritonavir, dasabuvir)

    Completed
    Has Results
    • Hepatitis C Infection
    • Hepatitis C Virus
    • (no location specified)
    Jul 28, 2021

    Chronic Hepatitis C, Chronic Hepatitis B Trial in Beijing (Tenofovir Alafenamide 25 MG, Sofosbuvir / Velpatasvir)

    Recruiting
    • Chronic Hepatitis C
    • Chronic Hepatitis B
    • Tenofovir Alafenamide 25 MG
    • Sofosbuvir / Velpatasvir
    • Beijing, Beijing, China
      Peking University First Hospital
    Aug 2, 2021

    Hepatitis C Infection, HIV Infection Trial in Washington, Bethesda (Nitazoxanide With Pegylated Interferon And Ribavirin)

    Completed
    Has Results
    • Hepatitis C Infection
    • HIV Infection
    • Nitazoxanide With Pegylated Interferon And Ribavirin
    • Washington, District of Columbia
    • +3 more
    Sep 14, 2021

    Chronic Hepatitis C Virus (HCV) Infection Genotype 1 Trial in United States (ABT-450/r/ABT-267, ABT-333, Ribavirin (RBV))

    Completed
    Has Results
    • Chronic Hepatitis C Virus (HCV) Infection Genotype 1
    • Phoenix, Arizona
    • +47 more
    Jun 27, 2022

    Chronic Hepatitis C Infection Trial (ABT-450/r/ABT-267, ABT-333, Ribavirin, Placebo for Ribavirin)

    Completed
    Has Results
    • Chronic Hepatitis C Infection
    • ABT-450/r/ABT-267, ABT-333
    • +2 more
    • (no location specified)
    Jul 8, 2021

    Chronic Hepatitis C Infection Trial (ABT-450/r/ABT-267, ABT-333, Ribavirin, Placebo for ribavirin)

    Completed
    Has Results
    • Chronic Hepatitis C Infection
    • ABT-450/r/ABT-267, ABT-333
    • +2 more
    • (no location specified)
    Jul 8, 2021

    Hepatitis C Virus Infection, Human Immunodeficiency Virus Infection, Chronic Hepatitis C Trial (ABT-450/r/ABT-267, ABT-333,

    Completed
    Has Results
    • Hepatitis C Virus Infection
    • +3 more
    • (no location specified)
    Jul 8, 2021

    Oral Glecaprevir/Pibrentasvir Tablets in Participants Aged 12

    Active, not recruiting
    • Hepatitis C Virus (HCV)
      • Chelyabinsk, Russian Federation
      • +9 more
      Mar 1, 2022

      Chronic Hepatitis C Infection Trial (ABT-450/r/ABT-267, ABT-333, Ribavirin, Placebo for ABT-450/r/ABT-267)

      Completed
      Has Results
      • Chronic Hepatitis C Infection
      • ABT-450/r/ABT-267, ABT-333
      • +4 more
      • (no location specified)
      Jul 29, 2021

      Hepatitis C, HCV Trial in San Antonio (TD-6450, Placebo)

      Completed
      • Hepatitis C
      • HCV
      • San Antonio, Texas
        Texas Liver Institute
      Jan 15, 2021